HGH News: Aegis Awarded New Patent for Stable Human Growth Hormone Injections Formulations

HRT getting started

HGH categories

HGH overview

HGH replacement

HGH scams

Take the first step by contacting us for a free consultation. Your information will remain confidential. * Indicates required field.
USA Citizens and Residents Only, Must be At least 30.
*Your Name:
*Day Phone:
*Evening Phone:
*Your Email:
*Confirm Email:
*Contact Time:
*Confirm Age Over 30:
*Confirm USA Citizen:
*Enter Code:

Please Fill In Above Details

Today is Saturday, May 19, 2012

HRT View

HGH News: Aegis Awarded New Patent for Stable Human Growth Hormone Injections Formulations

Aegis Awarded New Patent for Stable Human Growth Hormone Injections Formulations

Posted on: Wednesday, 17 September 2008, 12:00 CDT

Aegis Therapeutics, a drug delivery technology company, has received new US patent that provides broad protection for stabilized Human Growth Hormone Injections formulations.

The Aegis ProTek technology has been employed to create stabilized formulations of Human Growth Hormone Injections (hGH), insulin, antibodies, and other protein drugs that remain unchanged even after continuous agitation for many weeks or months at elevated temperatures.

The patented formulations are said to be suitable for intranasal delivery via a simple metered nasal spray as well as by standard injection or external drug infusion pump.

Aegis ProTek technology is expected to provide patients with safer, more convenient, non-injectable delivery options while extending the effective patent life of HGH Growth Hormone and other protein drugs.

Human growth hormone is a recombinant protein drug used in the treatment of pediatric and adult patients who have inadequate secretion of normal endogenous growth hormone.

http://www.redorbit.com

18 Sep 2008

HGH introduction

HGH solutions

HGH effects

HGH research

HGH regional

Buy Injectable HGH

HGH topics

HGH tests

HGH summary